A theme focused on growing the blood systems business, centered on apheresis, products for blood collection and blood centers, and cell processing and regenerative medicine products, by expanding indications and increasing adoption in emerging markets. While it includes international expansion, the focus is on growth in the specific blood and cell technology business.